Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule; Board on P National Academies Press (2013) Pehmeäkantinen kirja
Subcommittee on Immunotoxicology; Committee on Biologic Markers; Board on Environmental Studies and Toxicology; Commission on Li National Academies Press (1992) Kovakantinen kirja
Institute of Medicine; Division of Health Promotion and Disease Prevention; Division of Health Care Services; Committee on Immun National Academies Press (2000) Kovakantinen kirja
Committee on the Immunization Finance Dissemination Workshops; Division of Health Care Services; Institute of Medicine; National National Academies Press (2002) Pehmeäkantinen kirja
Committee on the Immunization Finance Dissemination Workshops; Board on Health Care Services; Institute of Medicine; National Ac National Academies Press (2002) Pehmeäkantinen kirja
Committee on the Immunization Finance Dissemination Workshops; Board on Health Care Services; Institute of Medicine; National Ac National Academies Press (2003) Pehmeäkantinen kirja
Institute of Medicine; Board on Health Promotion and Disease Prevention; Committee on the Review of the National Immunization Pr National Academies Press (2005) Pehmeäkantinen kirja
Vaccines are among the most safe and effective public health interventions to prevent serious disease and death. Because of the success of vaccines, most Americans today have no firsthand experience with such devastating illnesses as polio or diphtheria. Health care providers who vaccinate young children follow a schedule prepared by the U.S. Advisory Committee on Immunization Practices. Under the current schedule, children younger than six may receive as many as 24 immunizations by their second birthday. New vaccines undergo rigorous testing prior to receiving FDA approval; however, like all medicines and medical interventions, vaccines carry some risk. Driven largely by concerns about potential side effects, there has been a shift in some parents' attitudes toward the child immunization schedule. The Childhood Immunization Schedule and Safety identifies research approaches, methodologies, and study designs that could address questions about the safety of the current schedule. This report is the most comprehensive examination of the immunization schedule to date. The IOM authoring committee uncovered no evidence of major safety concerns associated with adherence to the childhood immunization schedule. Should signals arise that there may be need for investigation, however, the report offers a framework for conducting safety research using existing or new data collection systems.